The emerging legal cannabis industry is becoming one of the most dynamically developing sectors, as demonstrated by young CBD entrepreneurs in Germany. World High Life PLC is a company that knows how to reap the benefits of the wide acceptance of CBD products and medical cannabis, and the rise of new markets.
Hemp products are marketed throughout Germany and have already found their way into the country’s largest drug-store chains. Besides textiles and cosmetic products, hemp is also playing an important role as a medicinal plant. The main ingredient, CBD, has a calming effect. Numerous studies from the USA have proven the positive effect of CBD on well-being and especially on diseases such as migraines, ADHD, sleep disorders and rheumatism.
The “Green Gold” shop in Mainz
CBD has been legal in Germany since July 2019, so two Mainz-based companies have just opened a CBD shop in the old town.
The two owners, Hüseyin Dündar and Lokman Er, are from Mainz and have known each other since childhood. Both of them have been involved with CBD for more than two years. After the opportunity arose they didn’t want to wait too long and opened a branch in Mainz.
It is the first “Green Gold” shop outside of Hessen. The two owners described it as a “shop to touch”, where customers have the opportunity to inform themselves well and to receive advice.
Hüseyin and Lokman want to fight against the negative image of hemp and bring its positive effects in the foreground. Contrary to the general opinion, CBD does not make you high. Instead, “cannabidiol, or CBD for short, is said to have an anti-inflammatory and analgesic effect”.
The drug is used especially against depression and anxiety. It “de-stresses” the body and calms it down without altering perception. It is important that the THC content (the psychoactive component of hemp) of the product remains below 0.2 percent.
Hüseyin Dündar and Lokman Er want to make this effect better known through their new branch in Mainz. They sell a wide range of products, from CBD oil and balm to classic flowers. All products are 100-percent vegan and organic, and the legal control values are regularly checked by independent laboratories, said the two owners.
Following the relaxation of laws dealing with CBD and CBD derivatives by authorities in several European countries, experienced cannabis companies are eyeing the financial opportunities the new frontier market can bring.
World High Life reaps the benefits of the wide acceptance of CBD-based products in Europe
World High Life PLC (NEX: LIFE), a CBD and medical cannabis investment company, is aware of the huge potential Europe has in becoming the world’s largest CBD market in just a few years. Market analysts estimated that the value of the CBD market in Europe will be worth $1.7 billion by 2023, a 400% increase from the current value of $416 million.
World High Life is a company founded by two highly experienced North-Americans, the owners of two top cannabis companies, Supreme Cannabis (TSX:FIRE) and 1933 Industries (CSE:TGIF). The company’s strategy is to focus only on potential winners in the cannabis market and acquire them. World High Life plans to become the main player in the medical cannabis and CBD markets, and, to do so, it started the conquest of the emerging European cannabis sector.
In this respect, World High Life acquired Love Hemp LTD, the UK’s leading CBD company. Love Hemp’s CBD-based products, such as oils, CBD infused beverages, cosmetics and sprays are showcased in over 1,200 UK stores.
Love Hemp is planning to enter other European markets, starting with Germany in 2020. The groundbreaking partnership with World High Life PLC allows the company to scale up its expansion plans.
Employing the hard-won expertise and successful models from the North-American cannabis market, World High Life can ensure that previous mistakes won’t be repeated on the European cannabis market. WHL is not just another cannabis grower, it’s an investment company that offers investors the possibility to have access to a portfolio of top cannabis companies in the UK and Europe, all by purchasing a single stock.
Investing in cannabis companies that are yet to take off, but will do so in the next few years, is a gold mine you wouldn’t want to miss. Especially if you are aware of the opportunities you lost by not investing early in companies like Aphria or Canopy Growth, when their stocks were still at an affordable price.